Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer A Parikh

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
British Journal of Haematology|August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomesJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
British Journal of Haematology|August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomesJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Leukemia & Lymphoma|June 25, 2026
Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general populationLauren D Pomerantz, Kari G Rabe, Paul J Hampel, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.
Mayo Clinic Proceedings|June 5, 2026
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026Sameer A Parikh, Paul J Hampel, Lindsey E Roeker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Pageof 19